Skip to main content
Clinical Trials/NCT06547268
NCT06547268
Terminated
Not Applicable

Heart@Home: Advancing the Science of Pediatric Interstage Home Monitoring

Ann & Robert H Lurie Children's Hospital of Chicago1 site in 1 country2 target enrollmentJuly 24, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Defects, Congenital
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Enrollment
2
Locations
1
Primary Endpoint
Physiologic measurements
Status
Terminated
Last Updated
6 months ago

Overview

Brief Summary

The overall goal of this study is to understand the feasibility of using a wireless sensor device (instead of a wired device) to collect information used to monitor children with heart conditions at home.

Detailed Description

The goal of this study is to examine how well continuous sensor-based monitoring performs at detecting physiologic data in infants with single ventricle physiology at home compared to existing approaches, in manner that is feasible and acceptable to patients' families. Performance features of interest include how the data compares to family measurements, whether it correlates with parents' observable symptoms, and how this approach may be integrated into home life and health system workflows. The investigators will also explore whether the collected data can be used to develop predictive analytics for acute deterioration and/or advanced chronic cardiopulmonary management compared to what is currently being done in remote patient monitoring.

Registry
clinicaltrials.gov
Start Date
July 24, 2024
End Date
October 30, 2025
Last Updated
6 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Carolyn Foster

Assistant Professor of Pediatrics

Northwestern University

Eligibility Criteria

Inclusion Criteria

  • Receiving active remote patient monitoring (RPM) in Lurie's Tele-Interstage Home Monitoring Program.
  • Age 0-2 years of age at enrollment.
  • In the opinion of the investigator, parent or legally authorized guardian, and participant, the participant and (when relevant) family can follow study procedures.

Exclusion Criteria

  • Is going to discontinue RPM before their enrollment would end (i.e., within 14 days).
  • Skin breakdown or severe rash at the site of sensor placement.
  • Patient without a parental guardian to consent.
  • The patient is in active hospice or similar end-of-life care.
  • The patient will be living in a long-term institution or transitional facility.

Outcomes

Primary Outcomes

Physiologic measurements

Time Frame: up to 14 days per patient of data collection

Physiologic data waveform morphology

Secondary Outcomes

  • Systems Usability Score(up to 14 days per patient of data collection)
  • Utilization(up to 14 days per patient of data collection)

Study Sites (1)

Loading locations...

Similar Trials